121 related articles for article (PubMed ID: 12604232)
21. Enantioselective carbonyl reduction of eperisone in human liver microsomes.
Yoo HH; Kim NS; Kim MJ; Shin D; Shin JG; Kim DH
Xenobiotica; 2011 Sep; 41(9):758-63. PubMed ID: 21623702
[TBL] [Abstract][Full Text] [Related]
22. Carbonyl reduction of the potential cytostatic drugs benfluron and 3,9-dimethoxybenfluron in human in vitro.
Skálová L; Nobilis M; Szotáková B; Kondrová E; Savlík M; Wsól V; Pichard-Garcia L; Maser E
Biochem Pharmacol; 2002 Jul; 64(2):297-305. PubMed ID: 12123751
[TBL] [Abstract][Full Text] [Related]
23. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
24. Purification and characterization of 7beta-hydroxysteroid dehydrogenase from rabbit liver microsomes.
Shiotsuki H; Maeda Y; Chijiiwa K
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):185-90. PubMed ID: 15276626
[TBL] [Abstract][Full Text] [Related]
25. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli.
Blum A; Martin HJ; Maser E
Toxicology; 2000 Apr; 144(1-3):113-20. PubMed ID: 10781878
[TBL] [Abstract][Full Text] [Related]
26. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells.
Gavelová M; Hladíková J; Vildová L; Novotná R; Vondrácek J; Krcmár P; Machala M; Skálová L
Chem Biol Interact; 2008 Oct; 176(1):9-18. PubMed ID: 18755171
[TBL] [Abstract][Full Text] [Related]
27. Efficient isolation of carbonyl-reducing enzymes using affinity approach with anticancer drug oracin as a specific ligand.
Skarydová L; Andrýs R; Holubová L; Stambergová H; Kňavová J; Wsól V; Bílková Z
J Sep Sci; 2013 Apr; 36(7):1176-84. PubMed ID: 23495195
[TBL] [Abstract][Full Text] [Related]
28. Absence of type 1 11beta-hydroxysteroid dehydrogenase enzyme in koala liver.
Kong S; McKinnon RA; Mojarrabi B; Stupans I
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jan; 131(1):39-50. PubMed ID: 11796324
[TBL] [Abstract][Full Text] [Related]
29. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Ge RS; Gao HB; Nacharaju VL; Gunsalus GL; Hardy MP
Endocrinology; 1997 Jun; 138(6):2435-42. PubMed ID: 9165033
[TBL] [Abstract][Full Text] [Related]
30. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
Maser E; Wsol V; Martin HJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
[TBL] [Abstract][Full Text] [Related]
31. Role of cytochrome P4501A in biotransformation of the potential anticancer drug oracin.
Szotáková B; Wsól V; Skálová L; Kvasnicková E
Exp Toxicol Pathol; 1999 Jul; 51(4-5):428-31. PubMed ID: 10445410
[TBL] [Abstract][Full Text] [Related]
32. Functional and immunological relationships between metyrapone reductase from mouse liver microsomes and 3 alpha-hydroxysteroid dehydrogenase from Pseudomonas testosteroni.
Maser E; Oppermann UC; Bannenberg G; Netter KJ
FEBS Lett; 1992 Feb; 297(1-2):196-200. PubMed ID: 1551429
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3.
Novotna R; Wsol V; Xiong G; Maser E
Toxicol Lett; 2008 Sep; 181(1):1-6. PubMed ID: 18616992
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhetinic acid bound to 11 beta-hydroxysteroid dehydrogenase in rat liver microsomes.
Irie A; Fukui T; Negishi M; Nagata N; Ichikawa A
Biochim Biophys Acta; 1992 Nov; 1160(2):229-34. PubMed ID: 1445950
[TBL] [Abstract][Full Text] [Related]
35. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung.
Soldan M; Nagel G; Losekam M; Ernst M; Maser E
Cancer Lett; 1999 Oct; 145(1-2):49-56. PubMed ID: 10530769
[TBL] [Abstract][Full Text] [Related]
36. 11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone.
Bannenberg G; Martin HJ; Bélai I; Maser E
Chem Biol Interact; 2003 Feb; 143-144():449-57. PubMed ID: 12604231
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction.
Diederich S; Hanke B; Oelkers W; Bähr V
J Clin Endocrinol Metab; 1997 May; 82(5):1598-602. PubMed ID: 9141556
[TBL] [Abstract][Full Text] [Related]
38. Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11β-hydroxysteroid dehydrogenase 1.
Nishihara M; Takahashi J; Kondo T; Mouri K; Asahi S
Drug Res (Stuttg); 2014 Sep; 64(9):476-84. PubMed ID: 24357138
[TBL] [Abstract][Full Text] [Related]
39. Human 11beta-hydroxysteroid dehydrogenase type 1 is enzymatically active in its nonglycosylated form.
Blum A; Martin HJ; Maser E
Biochem Biophys Res Commun; 2000 Sep; 276(2):428-34. PubMed ID: 11027492
[TBL] [Abstract][Full Text] [Related]
40. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.
Diederich S; Eigendorff E; Burkhardt P; Quinkler M; Bumke-Vogt C; Rochel M; Seidelmann D; Esperling P; Oelkers W; Bähr V
J Clin Endocrinol Metab; 2002 Dec; 87(12):5695-701. PubMed ID: 12466373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
